Literature DB >> 14351971

SUPPURATIVE lymphadenitis following intradermal BCG vaccination of preschool children.

.   

Abstract

Regional lymph-node abscesses often occur among infants and young children following BCG vaccination, and the purpose of this study was to find ways to avoid glandular complications, or at least minimize their frequency, without jeopardizing the success of vaccination.Over 1,700 children ranging in age from 6 months to 7 years were vaccinated by one of nine different procedures obtained by various combinations of two strengths of vaccine, two depths of injection, and three volumes of vaccine, in an attempt to reproduce, experimentally, some of the kinds of variation that may occur in practical programmes. Follow-up examinations were made at 10 weeks and at one year, the local and glandular responses being observed and measured and the degree of tuberculin sensitivity assessed by an intradermal 10 TU test.BOTH THE DOSE OF VACCINE AND THE AGE OF THE CHILD WERE FOUND TO HAVE A STRIKING EFFECT ON THE FREQUENCY AND SEVERITY OF LYMPHADENITIS: the larger the dose and the younger the child, the higher the frequency of enlarged or perforated axillary lymph nodes. Furthermore, there was a close association between the findings at the two follow-up periods: with only one exception, children with negligible enlargement of the nodes at the 10-week examination had negligible findings at one year, whereas all the children with enlarged and adherent nodes at 10 weeks had evidence of perforation at one year.THE SIZE OF THE VACCINAL LESION WAS ALSO AFFECTED BY VACCINE DOSE AND BY AGE OF CHILD: the lesion was larger in the younger children and with the stronger doses. The degree of tuberculin sensitivity was affected only slightly by the variations in dose and still less by the age of the child.The size of the wheal raised by intradermal injection of vaccine was found to vary with the age of the child and with the depth of injection as much as it varied with the volume of vaccine injected. There can be no doubt that gauging the dose by the size of the wheal, rather than by the calibrations on a non-leaking syringe, is a very inaccurate procedure. When the dose of vaccine can be accurately measured, a stronger vaccine can be given (and perhaps a stronger degree of immunity attained) without causing an intolerable frequency of suppurative lymphadenitis.

Entities:  

Keywords:  BCG VACCINATION/complications; ETHYLAMINES/effects; LYMPHADENITIS

Mesh:

Substances:

Year:  1955        PMID: 14351971      PMCID: PMC2542325     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  An account of 2,500 infant B.C.G. vaccinations.

Authors:  H M PURSER
Journal:  Br Med J       Date:  1954-02-13

2.  [The shoulder, a region contraindicated for vaccination].

Authors:  G OLSEN
Journal:  Nord Med       Date:  1952-10-10

3.  [Complications of BCG vaccination in newborn].

Authors:  J I DE BRUIJNE; S VAN CREVELD; J R PRAKKEN; R H STOPPELMAN
Journal:  Ned Tijdschr Geneeskd       Date:  1952-10-25

4.  [Variation in technique of intracutaneous BCG vaccination].

Authors:  C E PALMER; P Q EDWARDS
Journal:  Br Med J       Date:  1953-02-14

5.  Measurement of leakage of tuberculin syringes.

Authors:  J GULD; C RUD
Journal:  Br Med J       Date:  1953-02-14

6.  Immunity to tuberculosis in infancy; with special reference to vaccination in the newborn.

Authors:  W GAISFORD; M GRIFFITHS
Journal:  Tubercle       Date:  1954-01

7.  BCG-vaccine studies. I. Effect of age of vaccine and variation in storage temperature and dosage on allergy production and vaccination lesions ten weeks after vaccination.

Authors:  L B EDWARDS; A S GELTING
Journal:  Bull World Health Organ       Date:  1950       Impact factor: 9.408

  7 in total
  2 in total

1.  Complications of BCG vaccinations in rural Haiti.

Authors:  H Bonnlander; A M Rossignol
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

2.  The Association of BCG Vaccination with Atopy and Asthma in Adults.

Authors:  Sung Soo Park; Eun Young Heo; Deog Kyeom Kim; Hee Soon Chung; Chang-Hoon Lee
Journal:  Int J Med Sci       Date:  2015-08-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.